Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Immunoconjugate for human CD66 for the treatment of multiple myeloma and other haematological malignancies

Immunoconjugate for human CD66 for the treatment of multiple myeloma and other haematological malignancies

US Patent 9072797 · Granted Jul 7, 2015

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Proteins with high immunoreactivity and method for their production2015
Bifunctional glycoproteins having a modified carbohydrate complement and their u2013
Proteins with high immunoreactivity and method for their production2010
Chimeric antibody against tumor associated antigens and its use in diagnosing tu2010
Effector conjugates, methods for their preparation and their pharmaceutical use2009
Effector conjugates, process for their production and their pharmaceutical use2008
Cytoplasmic expression of antibodies, antibody fragments and antibody fragment f2008
Fusion proteins for prodrug activation2007
Proteins with a high immunoreactivity and a method for the production thereof2007
Glycosyl-etoposide prodrugs, a process for preparation thereof and the use there2007
Effector conjugates, process for their production and their pharmaceutical use2006
Fusion proteins for prodrug activation2006